GLYCOSAMINOGLYCAN (GAG)

The Glycosaminoglycan (GAG) Test is a specialized laboratory test used to measure the amount of glycosaminoglycans (GAGs) in a biological sample, most commonly urine. This test plays an important role in the screening and diagnosis of mucopolysaccharidoses (MPS), a group of rare inherited metabolic disorders caused by deficiencies of enzymes responsible for breaking down glycosaminoglycans.

Glycosaminoglycans are long-chain complex carbohydrates that are naturally present in connective tissues, cartilage, skin, bones, blood vessels, and other body structures. Under normal conditions, the body continuously produces and breaks down these substances. In individuals with mucopolysaccharidosis, specific enzyme deficiencies prevent normal breakdown, leading to the accumulation of GAGs within cells and tissues. Over time, this buildup can damage multiple organs and body systems.

Children with MPS may develop symptoms such as developmental delay, coarse facial features, enlarged liver or spleen, joint stiffness, short stature, skeletal abnormalities, hearing loss, recurrent respiratory infections, heart valve disease, or vision problems. Because many of these symptoms develop gradually, laboratory screening is essential for early diagnosis and timely management.

The Glycosaminoglycan Test is often the first-line screening investigation when MPS is suspected. If elevated GAG levels are detected, additional confirmatory tests—including enzyme activity assays, genetic testing, and specialized metabolic evaluations—may be recommended to identify the specific type of MPS.

Doctors frequently recommend this test for infants, children, or occasionally adults who exhibit clinical features suggestive of lysosomal storage disorders or have a family history of inherited metabolic diseases.

Benefits of the Test

• Screens for mucopolysaccharidosis (MPS).
• Detects abnormal accumulation of glycosaminoglycans.
• Supports early diagnosis of inherited metabolic disorders.
• Helps identify children requiring further enzyme testing.
• Assists in evaluating unexplained developmental abnormalities.
• Non-invasive when performed on a urine sample.
• Supports early intervention and genetic counseling.
• Provides valuable information for pediatric metabolic specialists.

Why Doctors Recommend This Test

Doctors recommend the Glycosaminoglycan Test when symptoms suggest a lysosomal storage disorder such as mucopolysaccharidosis. It is commonly ordered for children with developmental delay, skeletal abnormalities, enlarged organs, or a family history of inherited metabolic disorders. The test serves as an important screening tool before confirmatory enzyme or genetic testing.

Preparation Before the Test

No special preparation is usually required.

If the test is performed using a urine sample, follow the laboratory's instructions regarding sample collection. Inform your healthcare provider about any medications, recent illnesses, or ongoing medical conditions. Depending on the clinical indication, either a urine or blood sample may be requested.

Normal Reporting Time

Typically: 3–7 Working Days

Reporting time may vary depending on laboratory methodology and specialized metabolic testing.

Who Should Take This Test?

This test is recommended for:

• Infants or children with suspected mucopolysaccharidosis (MPS).
• Children with developmental delay.
• Individuals with unexplained skeletal abnormalities.
• Patients with enlarged liver or spleen.
• Children with coarse facial features.
• Individuals with a family history of lysosomal storage disorders.
• Patients undergoing metabolic disease evaluation.
• Individuals referred by pediatricians, geneticists, or metabolic specialists.
• Patients with unexplained connective tissue abnormalities.
• Anyone advised by their healthcare provider.